Results 191 to 200 of about 5,136 (262)

Amelioration of convulsion-induced depression comorbidity by Rubus ellipticus whole plant extract in experimental models.

Indian J Pharmacol
Chand S, Das S, Mazumder A, Padhi S, Majee C, Pandey A, Das MK.   +6 more
europepmc   +1 more source

Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation. [PDF]

Pharmacol Rep
Łuszczki JJ, Kochman-Moskal E, Bojar H, Florek-Łuszczki M, Skalicka-Woźniak K.   +4 more
europepmc   +1 more source

Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways. [PDF]

Pharmacol Res Perspect
Balabandian M, Manavi MA, Lesani A, Mohammad Jafari R, Shafaroodi H, Heidari N, Mirnajafi-Zadeh J, Foroumadi A, Afrooghe A, Dehpour AR.   +9 more
europepmc   +1 more source

Maturation of GABAergic signalling times the opening of a critical period in Drosophila melanogaster

Corke J, Huertas Radi M, Landgraf M, Baines RA.   +3 more
europepmc   +1 more source

Involvement of GABA/BDZ receptors in the anticonvulsant effects of dihydrosanguinarine from <i>Bocconia arborea</i> S. Watson.

Heliyon
González-Gómez JD, Estrada-Soto S, Gaona-Tovar E, González-Trujano ME, Villasana-Salazar B, Narváez-González HF, Martínez-Vargas D.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Liability and Electroshock Therapy

Journal of Forensic Sciences, 1980
Abstract The malpractice status of the use of electroshock therapy (electroencephalotherapy) has been reviewed. In about 40 years, there have been relatively few reported cases dealing with EST (EET) and professional liability. Few cases have been won, and those generally for modest amounts. However, future successful claims are expected
openaire   +2 more sources

MARSILID (IPRONIAZID) AND ELECTROSHOCK

American Journal of Psychiatry, 1959
Marsilid (iproniazid), so far, is the only drug with powerful anti-depressive properties. Twenty-five out of 32 patients derived benefit from the drug. It is helpful [See TABLE-1 in source PDF] in depressive syndromes in which somatization and retardation predominate, particularly so, if strong neurotic features are present.
openaire   +2 more sources